Codagenix scores big with $20M Series B round
By GREGORY ZELLER // A stellar $20 million investment round has blasted a Long Island biotech into the stratosphere, and a new tax bracket. Farmingdale-based Codagenix Inc., a 2012 startup…
Steffan Mueller
Codagenix scores again: $3M to hunt down deadly RSV
By GREGORY ZELLER // A fresh $3 million in public and private investments has set Codagenix Inc. on the trail of another nefarious disease. Already developing vaccines for Zika virus,…
Codagenix, SUNY RF ink exclusive licensing deal
A year of big steps has led to one giant leap for Codagenix. Stony Brook University, through the Research Foundation for the State University of New York, has entered into…
Codagenix commences Zika vaccine testing
By GREGORY ZELLER // Farmingdale biotech Codagenix Inc. has commenced the first tests of its potential Zika virus vaccines in a living host. In a noteworthy display of speed sure to…
Move complete, Codagenix takes aim at Zika
By GREGORY ZELLER // Be afraid, Zika virus. With 1,500 square feet of new wet-lab space and buckets of confidence, the big thinkers at Codagenix are targeting your chemical code…